ANDREW OYELERE: Open Payments
NPI 1811356520 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,102 in 55 payments from 13 companies in 2025. Trend: 2023 $776 · 2024 $1,296 · 2025 $1,102
Food & beverage: $1,102
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $237 |
| Ardelyx, Inc. | 9 | $185 |
| Lilly USA, LLC | 8 | $173 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $168 |
| Novo Nordisk Inc | 4 | $70 |
| Daiichi Sankyo Inc. | 3 | $64 |
| Acera Surgical, Inc. | 2 | $54 |
| TELA Bio, Inc. | 1 | $40 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $29 |
Products named: IBSRELA, GATTEX, CREON, MOUNJARO, LINZESS, ZEPBOUND, INJECTAFER, Restrata Wound Matrix.
Industry payments across KS — which companies pay providers there.
